Evaluating individual radiosensitivity allows us to optimize radiotherapy treatment and thus improve the quality of life of patients.
A simple blood sample or a small skin biopsy is taken by the practitioner. From this sample, we isolate and cultivate the cells of interest in order to perform our predictive tests.
We provide a detailed report to the practitioner, a real decision-making tool. Practitioners can then use this report to adapt the patient's management.
Our solutions optimize the effectiveness of radiation treatments while preventing patient toxicity.
Our R&D unit's mission is to design innovative tests, develop them and optimize them to make them accessible to everyone.
You would like to discuss with us, you have any questions? Do not hesitate to contact us!